Rapid, low-sample-volume cholesterol and triglyceride assays
Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed. Assays may be performed in a single reaction mixture, allowing more accurate and precise cholesterol determinations, including ratios of cholesterol sub-fractions to total cholesterol, at less expense, than would be expected by performing several different assays in different reaction mixtures.
1. A reagent for use in a cholesterol assay, said reagent comprising a lipoprotein solubilization agent, lipoprotein interactant, and a buffer, wherein said lipoprotein interactant is present at a concentration level that provides for conversion of high density lipoprotein cholesterol (HDL-C) to a measureable colored product at a substantially different rate than for conversion of low density lipoprotein cholesterol (LDL-C) to a measureable colored product and at a substantially different rate than for conversion of very low density lipoprotein cholesterol (VLDL-C) to a measureable colored product when said reagent is used in a cholesterol assay;
wherein the lipoprotein interactant comprises a negatively charged polysaccharide and a divalent cation, or a salt thereof, in a ratio of between 0.003 to 0.007.
2. The reagent of claim 1 , comprising α-cyclodextrin sulfate, dextran sulfate, magnesium chloride, 4-aminoantipyrene and a sodium phosphate buffer.
3. The reagent of claim 2 , wherein said ratio of dextran sulfate to magnesium ions is between about 0.003 to about 0.005.
4. The reagent of claim 1 , said reagent comprising magnesium and dextran sulfate in a ratio of dextran sulfate to magnesium ions effective that there is no substantial precipitation of low-density lipoprotein (LDL), or that there is no substantial precipitation of very low-density lipoprotein (VLDL), or both, when a blood sample containing LDL or VLDL is put in contact with said reagent.
5. The reagent of claim 4 , wherein said ratio of dextran sulfate to magnesium ions is between about 0.003 to about 0.005.
6. The reagent of claim 1 , wherein said lipoprotein solubilization agent is selected from a surfactant, or a negatively charged α-cyclodextrin derivative; and said lipoprotein interactant comprises a low molecular weight negatively charged dextran derivative.
7. The reagent of claim 6 , wherein said ratio of dextran sulfate to magnesium ions is between about 0.003 to about 0.005.
8. The reagent of claim 1 , wherein said lipoprotein solubilization agent is a nonionic surfactant or a zwitterionic surfactant.
9. The reagent of claim 1 , wherein said lipoprotein interactant is a dextran derivative.
10. A kit comprising a reagent and instructions for the use of said reagent in a cholesterol assay, the reagent comprising α-cyclodextrin sulfate, dextran sulfate, magnesium chloride, 4-aminoantipyrene and a sodium phosphate buffer, wherein the ratio of dextran sulfate to magnesium ions in the reagent is between about 0.003 to about 0.007.